"And by 'in luck' I mean that the CEO and CMO of Mesoblast Ltd deserve (IMO) to be lauded for making the luck that Mesoblast Ltd and all its shareholders will enjoy over the next 2 years with BMT CTN."
Unfortunately shareholders wouldn't have a clue if this was the case, and cannot assume it as so, just because it is your opinion.
I would hope your opinion is correct, however the BoD have shown no care to informing shareholders, other than repeating themselves.
Cell Therapy News/Articles, page-17296
-
- There are more pages in this discussion • 525 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |